Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treosulfan based reduced toxicity conditioning followed by allogeneic stem cell transplantation in patients with myelofibrosis.
Claudiani S, Marktel S, Piemontese S, Assanelli A, Lupo-Stanghellini MT, Carrabba M, Guggiari E, Giglio F, De Freitas T, Marcatti M, Bernardi M, Corti C, Peccatori J, Lunghi F, Ciceri F. Claudiani S, et al. Among authors: peccatori j. Hematol Oncol. 2016 Sep;34(3):154-60. doi: 10.1002/hon.2183. Epub 2014 Dec 3. Hematol Oncol. 2016. PMID: 25469485
Incidence of human cytomegalovirus infection in patients with refractory solid tumors receiving nonmyeloablative allogeneic stem cell transplants versus recipients of standard SCT for hematologic malignancies.
Zambelli A, Lilleri D, Pedrazzoli P, Peccatori J, Baldanti F, Fregoni V, Ciceri F, Caldera D, Renga M, Colombo AA, Alessandrino EP, Gerna G, Da Prada GA, Siena S, Bregni M. Zambelli A, et al. Among authors: peccatori j. Biol Blood Marrow Transplant. 2005 Jun;11(6):423-8. doi: 10.1016/j.bbmt.2005.02.005. Biol Blood Marrow Transplant. 2005. PMID: 15931630 Free article. Clinical Trial.
Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation.
Peccatori J, Barkholt L, Demirer T, Sormani MP, Bruzzi P, Ciceri F, Zambelli A, Da Prada GA, Pedrazzoli P, Siena S, Massenkeil G, Martino R, Lenhoff S, Corradini P, Rosti G, Ringden O, Bregni M, Niederwieser D; European Bone Marrow Transplantation Solid Tumor Working Party. Peccatori J, et al. Cancer. 2005 Nov 15;104(10):2099-103. doi: 10.1002/cncr.21477. Cancer. 2005. PMID: 16220555 Free article.
Bone marrow mammaglobin expression as a marker of graft-versus-tumor effect after reduced-intensity allografting for advanced breast cancer.
Bregni M, Fleischhauer K, Bernardi M, Pescarollo A, Guggiari E, Lunghi F, Deola S, Scaramuzza S, Re F, Setola E, Monari M, Mazzi B, Servida P, Corradini P, Peccatori J. Bregni M, et al. Among authors: peccatori j. Bone Marrow Transplant. 2006 Feb;37(3):311-5. doi: 10.1038/sj.bmt.1705248. Bone Marrow Transplant. 2006. PMID: 16400340
Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe.
Barkholt L, Bregni M, Remberger M, Blaise D, Peccatori J, Massenkeil G, Pedrazzoli P, Zambelli A, Bay JO, Francois S, Martino R, Bengala C, Brune M, Lenhoff S, Porcellini A, Falda M, Siena S, Demirer T, Niederwieser D, Ringdén O; French ITAC group and the EBMT Solid Tumour Working Party. Barkholt L, et al. Among authors: peccatori j. Ann Oncol. 2006 Jul;17(7):1134-40. doi: 10.1093/annonc/mdl086. Epub 2006 Apr 28. Ann Oncol. 2006. PMID: 16648196 Free article. Clinical Trial.
Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation.
Ciceri F, Bonini C, Marktel S, Zappone E, Servida P, Bernardi M, Pescarollo A, Bondanza A, Peccatori J, Rossini S, Magnani Z, Salomoni M, Benati C, Ponzoni M, Callegaro L, Corradini P, Bregni M, Traversari C, Bordignon C. Ciceri F, et al. Among authors: peccatori j. Blood. 2007 Jun 1;109(11):4698-707. doi: 10.1182/blood-2006-05-023416. Epub 2007 Feb 27. Blood. 2007. PMID: 17327416 Free article.
Pre-transplant 18FDG-PET predicts outcome in lymphoma patients treated with high-dose sequential chemotherapy followed by autologous stem cell transplantation.
Crocchiolo R, Canevari C, Assanelli A, Lunghi F, Tassara M, Stanghellini ML, Clerici D, Landoni C, Servida P, Bernardi M, Peccatori J, Ferreri A, Gianolli L, Bordignon C, Caligaris-Cappio F, Ciceri F, Fazio F. Crocchiolo R, et al. Among authors: peccatori j. Leuk Lymphoma. 2008 Apr;49(4):727-33. doi: 10.1080/10428190701885545. Leuk Lymphoma. 2008. PMID: 18398740
Genomic typing for patient-specific human leukocyte antigen-alleles is an efficient tool for relapse detection of high-risk hematopoietic malignancies after stem cell transplantation from alternative donors.
Mazzi B, Clerici TD, Zanussi M, Lupo Stanghellini MT, Vago L, Sironi E, Peccatori J, Bernardi M, Carrera P, Palini A, Rossini S, Bordignon C, Bonini C, Ferrari M, Ciceri F, Fleischhauer K. Mazzi B, et al. Among authors: peccatori j. Leukemia. 2008 Nov;22(11):2119-22. doi: 10.1038/leu.2008.98. Epub 2008 May 1. Leukemia. 2008. PMID: 18449202 No abstract available.
131 results